Clinical Study Protocol for PENTILULA: A Phase 1/2 Study Assessing [(177)Lu]Lu-Pentixather for Relapsed or Refractory CXCR4-Positive Acute Leukemia.

Bodet-Milin C, Lelan F, François C, Chouin N, Carlier T, Gaschet J, Bourgeois M, Frindel M, Peterlin P, Hunault M, Moluçon-Chabrot C, Dumas PY, Kraeber-Bodéré F, Chevallier P

Open source

DOI: 10.2967/jnumed.126.273130
Published: 2026 Nov 5
Container: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2967/jnumed.126.273130,
  title = {Clinical Study Protocol for PENTILULA: A Phase 1/2 Study Assessing [(177)Lu]Lu-Pentixather for Relapsed or Refractory CXCR4-Positive Acute Leukemia.},
  author = {Bodet-Milin C and Lelan F and François C and Chouin N and Carlier T and Gaschet J and Bourgeois M and Frindel M and Peterlin P and Hunault M and Moluçon-Chabrot C and Dumas PY and Kraeber-Bodéré F and Chevallier P},
  year = {2026},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  doi = {10.2967/jnumed.126.273130},
  url = {https://doi.org/10.2967/jnumed.126.273130}
}

RIS

TY  - JOUR
TI  - Clinical Study Protocol for PENTILULA: A Phase 1/2 Study Assessing [(177)Lu]Lu-Pentixather for Relapsed or Refractory CXCR4-Positive Acute Leukemia.
AU  - Bodet-Milin C
AU  - Lelan F
AU  - François C
AU  - Chouin N
AU  - Carlier T
AU  - Gaschet J
AU  - Bourgeois M
AU  - Frindel M
AU  - Peterlin P
AU  - Hunault M
AU  - Moluçon-Chabrot C
AU  - Dumas PY
AU  - Kraeber-Bodéré F
AU  - Chevallier P
PY  - 2026
JO  - Journal of nuclear medicine : official publication, Society of Nuclear Medicine
DO  - 10.2967/jnumed.126.273130
UR  - https://doi.org/10.2967/jnumed.126.273130
ER  -

APA

C, B., F, L., C, F., N, C., T, C., J, G., M, B., M, F., P, P., M, H., C, M., PY, D., F, K., & P, C. (2026). Clinical Study Protocol for PENTILULA: A Phase 1/2 Study Assessing [(177)Lu]Lu-Pentixather for Relapsed or Refractory CXCR4-Positive Acute Leukemia.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. https://doi.org/10.2967/jnumed.126.273130

Source records

pubmed · retrieved 2026-11-10T11:03:39.008Z